Michel E. Bertrand

Michel E. Bertrand publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Michel E. Bertrand sits on this spectrum.

Michel E. Bertrand D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Michel E. Bertrand sits on this spectrum.

Overview

Best Publications

• Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).

  Lars Rydén;Eberhard Standl;Małgorzata Bartnik;Greet Van den Berghe

  2539
  Citations

• Strategies for Multivessel Revascularization in Patients with Diabetes

  Michael E. Farkouh;Michael Domanski;Lynn A. Sleeper;Flora S. Siami

  2119
  Citations

• Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study (CLASSICS).

  Michel E. Bertrand;Hans-Jürgen Rupprecht;Philip Urban;Anthony H. Gershlick

  1526
  Citations

• Angiographic follow-up after placement of a self-expanding coronary-artery stent.

  Patrick W. Serruys;Bradley H. Strauss;Kevin J. Beatt;Michel E. Bertrand

  950
  Citations

• Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.

  E J Topol;D J Moliterno;H C Herrmann;E R Powers

  876
  Citations

• Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study.

  M. E. Bertrand;Victor Legrand;J. Boland;E. Fleck

  836
  Citations

• Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography.

  M E Bertrand;J M LaBlanche;P Y Tilmant;F A Thieuleux

  677
  Citations

• Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation. Recommendations of the Task Force of the European Society of Cardiology

  M. E. Bertrand;M. L. Simoons;K. A. A. Fox;L. C. Wallentin

  569
  Citations

• Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin–angiotensin–aldosterone system inhibitors involving 158 998 patients

  Laura C. van Vark;Michel Bertrand;K. Martijn Akkerhuis;Jasper J. Brugts

  525
  Citations

• Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial

  Gregg W Stone;Harvey D White;E Magnus Ohman;Michel E Bertrand

  514
  Citations

• Impact of Bleeding on Mortality After Percutaneous Coronary Intervention: Results From a Patient-Level Pooled Analysis of the REPLACE-2 (Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events), ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy), and HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trials

  Roxana Mehran;Stuart Pocock;Eugenia Nikolsky;George D. Dangas

  502
  Citations

• Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting

  Deepak L Bhatt;Michel E Bertrand;Peter B Berger;Philippe L L’Allier

  496
  Citations

• Apolipoprotein A-I containing lipoproteins in coronary artery disease

  P. Puchois;A. Kandoussi;P. Fievet;J.L. Fourrier

  489
  Citations

• Restenosis rates in diabetic patients : A comparison of coronary stenting and balloon angioplasty in native coronary vessels

  Eric Van Belle;Christophe Bauters;Edouard Hubert;Jean-Christophe Bodart

  452
  Citations

• A Meta-Analysis of the Renal Safety of Isosmolar Iodixanol Compared With Low-Osmolar Contrast Media

  Peter A. McCullough;Michel E. Bertrand;Jeffrey A. Brinker;Fulvio Stacul

  445
  Citations

• Predictors of Restenosis After Coronary Stent Implantation

  Christophe Bauters;Edouard Hubert;Alain Prat;Karim Bougrimi

  413
  Citations

• Restenosis after coronary angioplasty

  M. Hamon;C. Bauters;E. P. McFadden;N. Wernert

  412
  Citations

• Early treatment of unstable angina in the coronary care unit: a randomised, double blind, placebo controlled comparison of recurrent ischaemia in patients treated with nifedipine or metoprolol or both

  F. L. Meijler;A. C. Arntzenuis;A. J. Dunning;P. G. Hugenholtz

  403
  Citations

• Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation The Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology*

  Michel E. Bertrand;Maarten L. Simoons;Keith A. A. Fox;Lars C. Wallentin

  196
  Citations

• Critical Issues in Peripheral Arterial Disease Detection and Management

  Jill J. F. Belch;Eric J. Topol;Giancarlo Agnelli;Michel Bertrand

  67
  Citations